Two contracts bring quicker, safer healthcare to approximately 1.1 million Southern Californians and Puerto Ricans
Glasgow, U.K.-based AxSys Technology, a provider of patient-centric clinical information solutions, has announced the signing of two major overseas contracts with one of the United States' largest providers of managed care services, Aveta.
Both North American Medical Management California (NAMM CA) and MSO of Puerto Rico, Inc (MSO)–Aveta's largest physician networks–will begin utilising AxSys' Excelicare clinical software platform. Each contract includes the development of a Health Information Exchange (HIE) system, which will give healthcare providers instant access to accurate information about patients in their care, in addition to other clinical functionalities provided by the flexible Excelicare platform.
Under these multi-million dollar contracts, Excelicare will be deployed as a community-wide clinical data repository with an HIE component. The new Excelicare ACE (Advanced Clinical Explorer) will provide community-wide access to a composite Continuity of Care Document (CCD) which will be created dynamically using the AxSys semantic data mapping technology. Along with Excelicare ACE, AxSys will also deploy a SureScripts certified ePrescribing solution and a patient personal health record (PHR) system at both these sites. The MSO contract in Puerto Rico also includes the Excelicare clinical application development environment.
Puerto Rico Deployment
Trial of the software among MSO patients and providers has been taking place throughout summer 2010. MSO hopes to have 8,000 providers using Excelicare by the end of the year – sharing data for approximately 100,000 patients.
MSO currently serves 6,000 providers, from primary care units to hospitals and specialists.
NAMM CA currently manages 250,000 lives and maintains a network of 500 primary care physicians and 1,000 specialists. Physicians, hospitals and other providers are expected to use Excelicare beyond this core, allowing information to be exchanged on a large population of patients in Southern California.